MG
GILD icon

Michael Gelband’s Gilead Sciences GILD Stock Holding History

Michael Gelband’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-104,663
Closed -$11.7M – 1642
2025
Q1 		$11.7M Buy
+104,663
New +$10.8M 0.12% 174
2024
Q4 		– Sell
-148,038
Closed -$12.4M – 1703
2024
Q3 		$12.4M Buy
148,038
+100,282
+210% +$7.65M 0.08% 200
2024
Q2 		$3.28M Buy
+47,756
New +$3.19M 0.02% 589
2023
Q3 		– Sell
-279,278
Closed -$21.5M – 1848
2023
Q2 		$21.5M Buy
+279,278
New +$22.3M 0.17% 97
2023
Q1 		– Sell
-129,276
Closed -$11.1M – 1890
2022
Q4 		$11.1M Buy
+129,276
New +$10.2M 0.16% 150
2022
Q3 		– Sell
-5,655
Closed -$350K – 2036
2022
Q2 		$350K Sell
5,655
-25,128
-82% -$1.56M ﹤0.01% 1477
2022
Q1 		$1.83M Buy
+30,783
New +$1.97M 0.02% 824
2021
Q1 		– Sell
-53,683
Closed -$3.13M – 2281
2020
Q4 		$3.13M Buy
53,683
+42,591
+384% +$2.57M 0.03% 386
2020
Q3 		$701K Sell
11,092
-16,198
-59% -$1.12M 0.01% 836
2020
Q2 		$2.1M Sell
27,290
-22,574
-45% -$1.73M 0.05% 404
2020
Q1 		$3.73M Buy
+49,864
New +$3.45M 0.2% 88
2019
Q4 		– Sell
-29,839
Closed -$1.89M – 1662
2019
Q3 		$1.89M Sell
29,839
-43,343
-59% -$2.83M 0.07% 255
2019
Q2 		$4.94M Sell
73,182
-18,634
-20% -$1.23M 0.2% 67
2019
Q1 		$5.97M Buy
91,816
+77,852
+558% +$5.17M 0.44% 33
2018
Q4 		$873K Buy
+13,964
New +$976K 0.06% 97

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Michael Gelband's GILD Position: Q2 2025 in Review

Michael Gelband sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 104,663 shares — an estimated $11.7M sold.

Michael Gelband first reported a position in GILD in Q4 2018 and held it in 15 quarters. The position peaked at $21.5M in Q2 2023. 2,025 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Michael Gelband reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Michael Gelband sold 104,663 Gilead Sciences shares in Q2 2025, an estimated $11.7M.
  • Michael Gelband first reported a position in Gilead Sciences in Q4 2018 and held it in 15 quarters.
  • Michael Gelband's Gilead Sciences position peaked at $21.5M in Q2 2023.
  • 2,025 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on ExodusPoint Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.